Loading... 2 0 5 0 false
Credit Name
Timothy Papaluca
Full Name
Papaluca, Timothy
 
 
Loading... 3 0 5 0 false

Publications

Results 1-4 of 4 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
15-Sep-2020Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics.Papaluca, Timothy ; Roberts, Stuart K; Strasser, Simone I; Stuart, Katherine A; Farrell, Geoffrey; MacQuillan, Gerry; Dore, Gregory J; Wade, Amanda J; George, Jacob; Hazeldine, Simon; O'Beirne, James; Wigg, Alan; Fisher, Leslie; McGarity, Bruce; Sawhney, Rohit; Sinclair, Marie ; Thomas, James; Valiozis, Ivan; Weltman, Martin; Wilson, Mark; Woodward, Aidan; Ahlenstiel, Golo; Haque, Mazhar; Levy, Miriam; Prewett, Emily; Sievert, William; Sood, Siddharth ; Tse, Edmund; Valaydon, Zina; Bowden, Scott; Douglas, Mark; New, Kate; O'Keefe, Jacinta; Hellard, Margaret; Doyle, Joseph; Stoove, Mark; Thompson, Alexander J
2Dec-2019Retreatment with Elbasvir, Grazoprevir, Sofosbuvir +/- Ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse.Papaluca, Timothy ; Sinclair, Marie ; Gow, Paul J ; Pianko, Stephen; Sievert, William; Arachchi, Niranjan; Cameron, Karla; Bowden, Scott; O'Keefe, Jacinta; Doyle, Joseph; Stoove, Mark; Hellard, Margaret; Iser, David; Thompson, Alexander
39-Jun-2018Exploring the feasibility of targeted chronic hepatitis B screening in the emergency department: A pilot study.Brock, Catherine; Yi, Yuan; Papaluca, Timothy ; Lucas, Benjamin; Angus, Peter W ; Taylor, David McD ; Leung, Christopher 
4Mar-2018Terlipressin: current and emerging indications in chronic liver diseasePapaluca, Timothy ; Gow, Paul J